December 2018
- Is the positive predictive value of high-grade cytology in predicting high-grade cervical disease falling due to HPV vaccination? Int J Cancer.
- Performance of clinical screening algorithms comprising point-of-care HPV-DNA testing using self-collected vaginal specimens, and visual inspection of the cervix with acetic acid, for the detection of underlying high-grade squamous intraepithelial lesions in Papua New Guinea. Papillomavirus Research.
November 2018
- Aboriginal women have a higher risk of cervical abnormalities at screening; South Australia, 1993-2016. J Med Screen.
- Clinical validation of the cobas HPV test on the cobas 6800 system for the purpose of cervical screening. J Clin Microbiol.
- Inaccurate and fundamentally flawed analysis risks undermining confidence in cervical screening programs. J Am Soc Cytopathol.
October 2018
- Anal cancer in high income countries: increasing burden of disease. PLOS One.
- The projected timeframe until cervical cancer elimination in Australia. Lancet PH.
- Potential for HPV vaccination and primary HPV screening to reduce cervical cancer disparities: example from New Zealand. Vaccine.
- Should cervical cancer screening be performed before age 25? J Low Genit Tract Dis.
- The impact of ten years of HPV vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent? Euro Surveill.
September 2018
August 2018
July 2018
- Human papillomavirus vaccination update: nonavalent vaccine and the two-dose schedule. Australian Journal of General Practice.
- Decline in prevalence of human papillomavirus infection following vaccination among Australian Indigenous women, a population at higher risk of cervical cancer: The VIP-I study. Vaccine.
June 2018
- Human Papillomavirus and Oropharyngeal Cancer Among Indigenous Australians: Protocol for a Prevalence Study of Oral-Related Human Papillomavirus and Cost-Effectiveness of Prevention. JMIR Res Protoc.
- Cervical screening in HPV-vaccinated populations. Climacteric.
- IPVS Statement Moving towards Elimination of Cervical Cancer as a Public Health Problem. Papillomavirus Research.
May 2018
- Spatial variation in cervical cancer screening participation & outcomes among Indigenous and non-Indigenous Australians in Queensland. Geographical Research.
- Final analysis of a study assessing genital human papillomavirus genoprevalence in young Australian women, following eight years of a national vaccination program. Vaccine.
- Comorbidity and cervical cancer survival of Indigenous and non-Indigenous Australian women: A semi-national registry-based cohort study (2003-2012). PLoS One.
April 2018
- Safety of human papillomavirus vaccines: An updated review. Drug Saf.
- National Cervical Screening Programme Annual Report 2015. National Screening Unit: Wellington.
March 2018
February 2018
- Very low prevalence of vaccine human papillomavirus (HPV) types among 18 to 35 year old Australian women, nine years following implementation of vaccination. Journal of Infectious Diseases.
- Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017–2035: Example from Australia. PLOS ONE.
January 2018
- Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25–69 years living in Australia. BMJ Open.
- A prospective study of the incidence of juvenile onset recurrent respiratory papillomatosis after implementation of a National HPV Vaccination Program. J Infect Dis.